Latest News and Press Releases

BitFuFu will release its fourth quarter and full year 2025 financial results before the U.S. market open on March 20, 2026.

AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update Phase 2 interim results suggest treatment with active immunotherapy ACI-7104 may slow the progression of Parkinson’s...

CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026

The Beauty Health Company reported fourth quarter and full year 2025 financial results reflecting continued improvement in margins and profitability.

Longeveron to report 2025 full year financial results and provide a business update on March 17, 2026 after the U.S. financial markets close.

JENA, Germany, March 12, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...

TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) today announced its fourth quarter (Q4) and full year results for the period ended December 31, 2025, along with an update on...

Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow

DP World reports strong 2025 financial results globally and across the Americas, driven by resilient trade demand and logistics growth.

Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update